Symphony: Timed Perfectly for the Pandemic

October 06, 2020 00:14:42
Symphony: Timed Perfectly for the Pandemic
John Lothian News Interviews
Symphony: Timed Perfectly for the Pandemic

Oct 06 2020 | 00:14:42

/

Show Notes

John Lothian interviewed David Gurle, the founder of Symphony, about how the company, its customers and prospective customers are responding to the provider of secure collaboration for global markets in light of the pandemic.

In this podcast conducted October 5, 2020, Gurle spoke of the demand for apps on the Symphony platform and the types that are being used. He talked about how his employees are using the Symphony platform like never before and what they miss while doing so.

Gurle said over 80 to 90 percent of his meetings are now over Symphony and that his employees could continue to work from home forever now, something he did not think about before the pandemic.

He spoke about the types of firms that Symphony is looking to bring on board, and how their marketing has gone virtual, but word of mouth remains their strongest method.

And lastly, he talked about growth at Symphony and their plans for future acquisitions to help augment it.

Here is the John Lothian News interview with Symphony founder David Gurle, conducted by John Lothian.

Other Episodes

Episode 33

March 24, 2023 00:23:29
Episode Cover

Exchange Analytics' Joe Adamczyk Interviewed by John Lothian On the Road in Sarasota

New(ish) Owner of Exchange Analytics Talks Company History and Future in JLN Podcast During my recent trip to Florida, I met up with Joe...

Listen

Episode

June 30, 2023 00:38:24
Episode Cover

WH Trading Spawned a Social Justice Phenomena in My Hood, My Block, My City

At a recent meeting of the social justice committee at my church, St. Peter's UCC in Elmhurst, IL, I was asked to look into...

Listen

Episode

June 18, 2023 00:18:10
Episode Cover

FTSE Russell Reconstitution Podcast Interview with Catherine Yoshimoto and Tim McCourt

John Lothian News interviewed Tim McCourt, Global Head of Financial and OTC Products at the CME Group and Catherine Yoshimoto, Director of Product Management...

Listen